Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
39 studies found for:    " February 24, 2010":" March 26, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" February 24, 2010":" March 26, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men
Conditions: HIV Prevention;   HIV Infections
Intervention: Drug: Raltegravir
2 Completed Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants
Conditions: HIV-1 Infection;   HIV Infections
Intervention: Biological: PENNVAX-B
3 Completed
Has Results
Study of Vitamin D and Effect on Heart Disease and Insulin Resistance
Conditions: HIV;   Vitamin D Deficiency;   HIV Infections
Intervention: Drug: Vitamin D
4 Completed
Has Results
Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: Atripla
5 Recruiting Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection
Conditions: HIV;   HIV Infections
Intervention:
6 Completed
Has Results
Vitamin D Dose Finding Study
Conditions: HIV Infections;   AIDS
Intervention: Drug: Cholecalciferol  (Vit D3)
7 Recruiting Kaletra in Combination With Antiretroviral Agents
Condition: Human Immunodeficiency Virus
Intervention:
8 Completed
Has Results
Special Investigation of Kaletra in Pregnant Women
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
9 Recruiting Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet
Condition: Human Immunodeficiency Virus
Intervention:
10 Completed
Has Results
Evaluation of Kaletra Therapy Over the Long-term
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
11 Completed
Has Results
Drug Use Investigation of Kaletra
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
12 Completed
Has Results
Long-term Effectiveness and Safety in Hepatitis-co-infected Patients
Condition: Human Immunodeficiency Virus-Infection
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
13 Completed Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy
Conditions: HIV Infection;   Antiretroviral Side Effects;   Lipodystrophy Syndrome Related to HIV Infection
Intervention: Device: Eutrophill
14 Completed Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status
Conditions: Fracture;   Infection, Human Immunodeficiency Virus
Interventions: Other: No Antiretroviral (ARV) Drug Exposure;   Drug: Any Antiretroviral (ARV) Drug Exposure
15 Completed TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected Patients
Condition: HIV-Infections
Intervention: Drug: etravirine
16 Completed
Has Results
HIV and Fat Accumulation
Condition: HIV Infection
Intervention: Drug: Telmisartan
17 Completed PENTA Fosamprenavir Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Exposure to licensed dose of FPV (+/- 20% of 18mg/kg BID + RTV)
18 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
19 Active, not recruiting Using Incentives to Improve Parolee Participation and Attendance in Community Treatment
Conditions: Substance Abuse;   HIV Infections
Interventions: Behavioral: Contingency management: voucher/monetary incentives for treatment attendance;   Behavioral: Information
20 Completed
Has Results
Mesalamine to Reduce T Cell Activation in HIV Infection
Conditions: HIV Infections;   Sexually Transmitted Diseases;   Immune System Diseases;   Lentivirus Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Mesalamine (5-aminosalicylic acid, Apriso);   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Indicates status has not been verified in more than two years